Elicio Therapeutics
ELTX
ELTX
18 hedge funds and large institutions have $2.78M invested in Elicio Therapeutics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$287K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$137K |
| 3 |
Renaissance Technologies
New York
|
+$137K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$16.7K |
| 5 |
BlackRock
New York
|
+$7.65K |
Top Sellers
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$254K |
| 2 |
Millennium Management
New York
|
-$172K |
| 3 |
CM
CM Management
Gulf Breeze,
Florida
|
-$125K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$18.4K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$4.44K |
